Literature DB >> 2507065

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.

E Nordborg1, B A Bengtsson.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2507065      PMCID： PMC1837376          DOI： 10.1136/bmj.299.6698.549

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Giant-cell arteritis. Signs and symptoms.

Authors:  J L Keltner
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

2.  Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids.

Authors:  R Andersson; B E Malmvall; B A Bengtsson
Journal:  Acta Med Scand       Date:  1986

3.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.

Authors:  K A Huston; G G Hunder; J T Lie; R H Kennedy; L R Elveback
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

4.  Giant cell arteritis as a cause of death. Report of nine cases.

Authors:  J Säve-Söderbergh; B E Malmvall; R Andersson; B A Bengtsson
Journal:  JAMA       Date:  1986 Jan 24-31       Impact factor: 56.272
  4 in total
  20 in total

1.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

2.  Cough as the presenting symptom of large vessel vasculitis.

Authors:  B Van der Schueren; M Lambert
Journal:  Clin Rheumatol       Date:  2005-01-14       Impact factor: 2.980

3.  Giant cell arteritis.

Authors:  J C Mason; M J Walport
Journal:  BMJ       Date:  1992-07-11

4.  Morphological features of temporal arteritis.

Authors:  William C Roberts; Saleha Zafar; Jo Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

5.  Temporal arteritis.

Authors:  Andrew W Lee; Celia Chen; Sudha Cugati
Journal:  Neurol Clin Pract       Date:  2014-04

6.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

Review 7.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

8.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Sherine E Gabriel; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

Review 9.  Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.

Authors:  G Nesher; M Sonnenblick
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

10.  Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.

Authors:  E Nordborg; T Hansson; R Jonson; J Szücs; B A Bengtsson
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.